GE HealthCare (NASDAQ: GEHC) posts Q4 and full-year 2025 results update

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. furnished an 8-K to announce that it issued a press release with its fourth quarter 2025 and full-year 2025 financial results. The press release, dated February 4, 2026, is included as Exhibit 99 and is provided under Item 2.02, Results of Operations and Financial Condition.

The company notes that the information in Item 2.02, including Exhibit 99, is furnished rather than filed, so it is not subject to certain Exchange Act liabilities and is not automatically incorporated into other securities law filings. The 8-K also lists Exhibit 104, the cover page formatted in Inline XBRL, and is signed by the Controller and Chief Accounting Officer.

0001932393false00019323932026-02-042026-02-04

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 4, 2026

GE HEALTHCARE TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

Delaware

001-41528

88-2515116

(State or other jurisdiction of incorporation)

(Commission  File Number)

(IRS Employer Identification No.)

500 W. Monroe Street, Chicago, IL

60661

(Address of principal executive offices)

(Zip Code)

(Registrant’s telephone number, including area code) (833) 735-1139

______________________________________________

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.01 per share

GEHC

The Nasdaq Stock Market LLC

			Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
			Emerging growth company			☐
			If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.			☐

Item 2.02 Results of Operations and Financial Condition.

On February 4, 2026, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its fourth quarter 2025 and fiscal year ended December 31, 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K.

The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit			Description
99			Press release of GE HealthCare Technologies Inc., dated February 4, 2026.
104			The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						GE HealthCare Technologies Inc.
						(Registrant)
Date: February 4, 2026						/s/ George A. Newcomb
						George A. Newcomb, Controller & Chief Accounting Officer (authorized signatory)

FAQ

What did GEHC disclose in its latest 8-K filing?

GE HealthCare Technologies Inc. disclosed that it issued a press release announcing its fourth quarter 2025 and full-year 2025 financial results. The press release is attached as Exhibit 99 and is furnished under Item 2.02, covering results of operations and financial condition.

When did GEHC release its Q4 and full-year 2025 financial results?

GE HealthCare released its fourth quarter 2025 and full-year 2025 financial results in a press release dated February 4, 2026. This press release is referenced in a Form 8-K and furnished as Exhibit 99, rather than being incorporated as filed financial statements.

How are GEHC’s Q4 2025 results treated for SEC liability purposes?

The fourth quarter 2025 and full-year 2025 results are provided in a press release furnished, not filed, under Item 2.02 of the 8-K. GE HealthCare states this information is not subject to Section 18 Exchange Act liabilities and is not incorporated into other filings unless specifically referenced.

Where can investors find GEHC’s detailed Q4 and 2025 financial figures?

Investors can find the detailed fourth quarter 2025 and full-year 2025 financial figures in the press release attached as Exhibit 99 to the Form 8-K. The filing itself mainly references the exhibit rather than repeating the financial data in the body text.

What exhibits are included with GEHC’s February 4, 2026 8-K?

The 8-K includes Exhibit 99, which is the press release containing GE HealthCare’s Q4 2025 and full-year 2025 results, and Exhibit 104, which is the cover page formatted in Inline XBRL. These exhibits accompany the company’s furnished earnings disclosure.

Who signed GEHC’s 8-K reporting Q4 and 2025 results?

The 8-K reporting the issuance of GE HealthCare’s Q4 2025 and full-year 2025 results press release was signed by George A. Newcomb. He is identified in the document as the company’s Controller and Chief Accounting Officer and an authorized signatory.